Can-Fite Wins Patent, Shares Flat
Can-Fite BioPharma Ltd. (NYSE: CANF), shares barely budged Monday as the biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory ...
US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug
The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety ...
Frontiers1mon
Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome”
Figure 1. Relationships between MAFLD and metabolic disorders that increase cardiovascular risk. The association between MAFLD and renal dysfunction is intriguing and has been highlighted in recent ...
Frontiers1mon
Circulating levels of adiponectin and AdipoR expression in peripheral blood mononuclear cells are associated with lower respiratory tract Infection
We aimed to measure APN and its signaling receptors, adiponectin receptor (AdipoR), in peripheral blood mononuclear cells (PBMCs) from LRTI patients to explore their potential roles in the LRTI ...
ahajournals.org2mon
GSK3β Deficiency Expands Obese Adipose Vasculature to Mitigate Metabolic Disorders
Department of Biomedical Sciences, Faculty of Health Sciences (L.W., J.L., P.T., D.Z., L.T., Y.W., L.D.), University of Macau, China. The Ministry of Education ...